Search results

• Active

  CoL: CRUK City of London Centre renewal (COLMC)

  Ng, T., Arnold, J., Blower, P., Ciccarelli, F., Dazzi, F., Farzaneh, F., Grigoriadis, A., Hayday, A., Irshad, S., Kong, A., Kordasti, S., Lawrence, T., Mishto, M., Papa, S., Purushotham, A., Quek, L., Ramsay, A., Reis Ferreira, M., Sarker, D., Sinkus, R., Spicer, J. & Witney, T.

  CRUK Cancer Research UK

  1/04/2022 → 31/03/2027

  Project: Research

• MRC-LifeArc: King’s/Royal Free/UCL Gene Therapy Innovation Hub

  Ali, R. & Farzaneh, F.

  MRC Medical Research Council

  1/10/2021 → 30/09/2026

  Project: Research

• KHP Centre Award - Non-Clinical Training Award

  Parker, P., Spicer, J., Ciccarelli, F., Dazzi, F., Farzaneh, F., Hayday, A., Maher, J., Ng, T., Papa, S., Purushotham, A. & Sarker, D.

  CRUK Cancer Research UK

  1/04/2017 → 31/03/2025

  Project: Research

  • Awards 100%
  • Training 80%
  • Award 20%
  • Cancer Research 20%
  • Health 20%
• Finished

  CNSL: GMP Vector Production - CNSL - University College London

  Farzaneh, F.

  Wellcome Trust

  1/08/2020 → 30/09/2022

  Project: Research

• Production of expanded autologous regulatory T cells to treat patients with refractory aplastic anaemia in a phase I dose study

  Mufti, G., Lombardi, G., Flach, C. & Farzaneh, F.

  Aplastic Anaemia Trust

  18/11/2019 → 31/01/2023

  Project: Research

• AML-2: CD80/IL-2 Immune Gene Therapy for Poor Prognosis Acute Myeloid Leukaemia

  Farzaneh, F. & Mufti, G.

  J P Moulton Charitable Foundation

  1/09/2019 → 31/08/2022

  Project: Research

• Deep Conditioning using CRISPR edited T cells

  Farzaneh, F.

  Wellcome Trust

  1/07/2019 → 30/11/2023

  Project: Research

• Viral vector gene therapy for FTD and ALS: from constructs to clinical trials

  Shaw, C., Lee, Y. & Farzaneh, F.

  UK Dementia Research Institute

  1/01/2019 → 31/12/2022

  Project: Research

• VAPER: A Phase 1 Cancer Vaccine Trial

  Spicer, J. & Farzaneh, F.

  Guy's & St Thomas' Charity

  11/09/2018 → 4/06/2021

  Project: Research

• BCMA as a CAR-T Cell and mechanisms of target escape

  Benjamin, R., Farzaneh, F. & Martins Metelo, A.

  KHP King's Health Partners

  1/06/2018 → 30/09/2018

  Project: Research

• Size selective nanocone biosensor for detecting viral vectors for gene therapy

  Dickson, W. & Farzaneh, F.

  EPSRC Engineering and Physical Sciences Research Council

  1/04/2018 → 31/07/2018

  Project: Research

  • Gene Therapy 100%

• Vaccination-mediated immunity against tumour recurrence in oesophago-gastric adenocarcinoma

  Lagergren, J. & Farzaneh, F.

  Guy's & St Thomas' Charity

  1/01/2018 → 31/12/2018

  Project: Research

• Genetically engineered mesenchymal stromal cells producing anti-CTLA-4 antibodies as targeted checkpoint inhibitor therapy in pancreatic cancer in KPC mouse model

  Dazzi, F. & Farzaneh, F.

  1/06/2017 → 1/06/2021

  Project: Research

• Organoid cell therapy for paediatric acute liver failure: Bridging bench to bedside strategies

  Dhawan, A. & Farzaneh, F.

  1/05/2017 → 30/04/2022

  Project: Research

• Adaptation of former HeLa based Cancer-Killing Assay of human leukocytes to be based on Pancreatic Cancer cells in order to increase the specificity of the assay in Pancreatic Cancer

  Farzaneh, F.

  GLA Greater London Authority

  1/04/2017 → 31/03/2019

  Project: Research

• Pre-Clinical development of a Stem Cell based Gene Therapy protocol and clinical proof of principle for Duchenne Muscular Dystrophy

  Farzaneh, F.

  Wellcome Trust

  1/06/2016 → 31/05/2019

  Project: Research

• Next generation CAR19 studies

  Farzaneh, F.

  NIHR National Institute For Health & Care Research

  1/11/2015 → 30/04/2019

  Project: Research

• Large scale lentiviral vector production

  Farzaneh, F. & Chan, L.

  BBSRC Biotechnology and Biological Sciences Research Council

  1/11/2015 → 31/10/2018

  Project: Research

• In Vivo Generation of Optimal Tumour Antigen-specific Anticancer Immune Responses, by Vaccination with Human Telomerase Reverse Transcriptase (hTERT) Peptides, in Combination with Specific Adjuvants and Elimination of Immunosuppressive Regulatory Cells, in Patients with Advanced Cancer. Phase 1 Study (VAPER)

  Spicer, J. & Farzaneh, F.

  Candles

  1/07/2015 → 31/12/2019

  Project: Research

• Next Generation Studies

  Farzaneh, F.

  1/04/2015 → 31/03/2018

  Project: Research

• Pre-emptive immune therapy to prevent relapse of myeloid malignancies

  Barber, L., Farzaneh, F., Lombardi, G., Maher, J., Mufti, G. & So, E.

  Blood Cancer UK

  1/08/2013 → 31/12/2017

  Project: Research

• An immunisation strategy to prevent hepatocellular carcinoma

  Farzaneh, F., Harrison, P., Noble, A. & Noelle, R.

  1/04/2013 → 31/03/2015

  Project: Research

• Development of enhanced gene specific technology for the isolation of proteins binding at a single locus in vivo

  Farzaneh, F. & Ford, K.

  BBSRC Biotechnology and Biological Sciences Research Council

  1/03/2013 → 26/08/2014

  Project: Research

• Novel non-coding RNAs conrolling cell fate during leukaemia development and therapy

  Farzaneh, F.

  1/01/2013 → 1/01/2015

  Project: Research

• NIHR Clinical Research Facility infrastructure

  McGregor, A., Farzaneh, F. & Williams, S.

  NIHR National Institute For Health & Care Research

  1/09/2012 → 31/03/2017

  Project: Research

• Development of a Vaccine for the Treatment of hepatitis B v infection

  Harrison, P., Farzaneh, F. & Noble, A.

  1/06/2012 → 31/05/2013

  Project: Research

• An immunisation strategy to prevent hepatocellular carcinoma

  Harrison, P., Farzaneh, F. & Noble, A.

  1/05/2012 → 30/04/2015

  Project: Research

• Experimental Cancer Medicine Centre

  Purushotham, A., Spicer, J., Farzaneh, F., Hayday, A., Holmberg, L., Karagiannis, S., Nestle, F., Ng, T., Parker, P., Pinder, S. & Sarker, D.

  CRUK Cancer Research UK

  1/04/2012 → 31/03/2017

  Project: Research

• 'T4 immunotherapy' of head and neck cancer using genetically engineered T-cells

  Maher, J., Farzaneh, F. & Spicer, J.

  J P Moulton Charitable Foundation

  1/02/2012 → 30/04/2021

  Project: Research

• A Phase-I study of lentivirus transduced acute myeloid leukaemic cells expressing B7.1 (CD80) and IL-2 for the potential induction of graft versus leukaemia (GVL) effect in poor prognosis AML

  Farzaneh, F.

  1/02/2012 → 31/01/2015

  Project: Research

• Innate Immune Responses In Hepatitis Delta Virus Infection

  Harrison, P., Farzaneh, F. & academic, A.

  1/10/2011 → 30/09/2014

  Project: Research

• Development of a Theraputic Vaccine for the Treatment of Hepatitis B virus Infection

  Harrison, P., Farzaneh, F. & Noble, A.

  1/10/2011 → 30/09/2013

  Project: Research

• Abrogating CD8 T cell tolerance to tumour-associated antigens

  Noble, A. & Farzaneh, F.

  1/05/2011 → 30/04/2014

  Project: Research

• Development of a therapeutic HBV vaccine

  Harrison, P., Noble, A. & Farzaneh, F.

  1/03/2011 → 28/02/2015

  Project: Research

• Immune dysregulation in bone marrow failure syndromes: implications for pathogenesis and clonal evolution.

  Mufti, G., Farzaneh, F., Thomas, S. & Kordasti, S.

  Blood Cancer UK

  1/10/2010 → 28/02/2021

  Project: Research

• Immune biology and immune therapy of acute myeloid leukaemia

  Farzaneh, F. & Mufti, G.

  1/03/2010 → 28/02/2013

  Project: Research

• Gene therapy clinical trial

  Farzaneh, F. & Mufti, G.

  Leukaemia UK

  1/03/2010 → 28/02/2013

  Project: Research

• Development of a therapeutic HBC vaccine

  Farzaneh, F. & Thomas, S.

  1/01/2010 → 31/12/2012

  Project: Research

• Development of a therapeutic HBV vaccine

  Farzaneh, F., Harrison, P., Hui, K. M., Noble, A. & Ooi, L. L.

  1/01/2010 → 31/12/2011

  Project: Research

• Two dimensional ultra high-pressure high resolution liquid chromatography and mass spectrometry for multi-user advanced bioanalysis.

  Cowan, D., Bansal, S., Farzaneh, F., Hider, R., Hogstrand, C., Parkin, M. & Thomas, S.

  1/01/2010 → 31/12/2014

  Project: Research

• Two dimensional ultra high-pressure high resolution liquid chromatography and mass spectrometry for multi-user advanced bioanalysis

  Cowan, D., Bansal, S., Farzaneh, F., Hider, R., Hogstrand, C., Parkin, M. & Thomas, S.

  1/01/2010 → 31/12/2014

  Project: Research

• A comprehensive programme in Leukaemia Immune Therapy

  Farzaneh, F. & Mufti, G.

  1/01/2010 → 31/12/2012

  Project: Research

• Immune therapy of Leukaemia and multiple myeloma

  Farzaneh, F. & Schey, S.

  Cancer Vaccines Institute

  1/10/2009 → 30/09/2011

  Project: Research

• Immunotherapy of ovarian cancer using t-cells engrafted with chimeric antigen and cytokine receptors

  Burchell, J., Maher, J., Farzaneh, F. & Mullen, G.

  1/09/2009 → 31/08/2012

  Project: Research

• Adoptive immunotherapy of metastatic prostate cancer using PSMA re-targeted T-lymphocytes

  Antoniou, M., Maher, J., Chowdhury, P., Farzaneh, F., Mullen, G. & Papa, S.

  1/05/2009 → 30/04/2012

  Project: Research

• Identification of the tumour-specific apoptin kinases

  Tavassoli, M. & Farzaneh, F.

  CRUK Cancer Research UK

  1/10/2008 → 30/09/2012

  Project: Research

• CRUK Doctoral Training Fellowship

  Farzaneh, F. & Tavassoli, M.

  1/10/2008 → 30/09/2012

  Project: Research

• Formulation of MAS-1 adjuvant with innate immune activators to induce CD8+ T cell-mediated immunity by tumour-specific antigens for the immunotherapy of cancer

  Noble, A. & Farzaneh, F.

  1/04/2008 → 31/03/2010

  Project: Research

• NIHR Biomedical Research Centre

  Afzali, B., Antoniou, M., Barker, J., Barratt, B., Beighton, D., Bevan, S., Blower, P., Burchell, J., Cason, J., Chappell, L., Cope, A., Corrigan, C., Cunninghame Graham, D., Dontu, G., Edgeworth, J., Farzaneh, F., Gee, T., Gould, H., Green, P., Greenough, A., Grigoriadis, A., Hayday, A., Higginson, I., Kalra, L., Karagiannis, S., Kelly, F., Kemper, C., Lau-Walker, M., Lavender, P., Lee, T., Lempp, H., Lewis, C., Lombardi, G., Lord, G., Marber, M., Mason, J., Mathew, C., McGrath, J., Metcalfe, A., Molokhia, M., Mullen, G., Nagel, E., Neil, S., Nestle, F., Oakey, R., Parker, P., Peakman, M., Perera, D., Purushotham, A., Rasekh Ahmadi, K., Rashid, T., Razavi, R., Ridley, A., Robson, M., Sacks, S., Sanchez Fueyo, A., Santis, G., Sanz Moreno, V., Sawyer, E., Schaeffter, T., Shah, A., Sharpe, P., Simpson, M., Smith, R., Sorinola, I., Spector, T., Spicer, J., Taams, L., Tavassoli, M., Taylor, D., Tree, T., Trembath, R., Tribe, R., Tutt, A., Waltham, M., Watt, F., Webb, A., Wells, C., Whelan, K., Whitaker, J., Whittlesea, C., Williamson, C., Wolfe, C., Yu, V., academic, A., Hughes, S., Montana, G., Rhode, K., Schnabel, J. & Tziotzios, C.

  NIHR National Institute For Health & Care Research, DHSC Department of Health and Social Care

  1/04/2007 → 31/03/2017

  Project: Research

  • T-Helper Cell 100%
  • Inflammatory Arthritis 66%
  • Monocyte 36%
  • Tumor Necrosis Factor 36%
  • Cytotoxic T-Cell 33%

• BRIC: packaging cell lines for inherently manufacturable human vectors

  Farzaneh, F. & Darling, D.

  BBSRC Biotechnology and Biological Sciences Research Council

  1/10/2006 → 31/03/2010

  Project: Research